Vespa crabro chromosome 10, iyVesCrab1.2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespa.
REFSEQ INFORMATION: The reference sequence is identical to\nOU342409.1.\nAssembly name: iyVesCrab1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/02/09. The original whole-genome shotgun project has the\naccession CAJUUB000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespa crabro Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
uncharacterized LOC124427684, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124427684, transcript variant X1
uncharacterized LOC124427684, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
N-terminal kinase-like protein, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
N-terminal kinase-like protein isoform X1
N-terminal kinase-like protein, transcript variant X2
N-terminal kinase-like protein isoform X2
probable glucosamine 6-phosphate N-acetyltransferase
uncharacterized LOC124427683, transcript variant X1
uncharacterized LOC124427683, transcript variant X2
bromodomain adjacent to zinc finger domain protein 1A, transcript variant X2
bromodomain adjacent to zinc finger domain protein 1A, transcript variant X6
bromodomain adjacent to zinc finger domain protein 1A, transcript variant X5
bromodomain adjacent to zinc finger domain protein 1A, transcript variant X3
bromodomain adjacent to zinc finger domain protein 1A, transcript variant X4
bromodomain adjacent to zinc finger domain protein 1A, transcript variant X1
bromodomain adjacent to zinc finger domain protein 1A, transcript variant X7
bromodomain adjacent to zinc finger domain protein 1A isoform X5
bromodomain adjacent to zinc finger domain protein 1A isoform X4
bromodomain adjacent to zinc finger domain protein 1A isoform X2
bromodomain adjacent to zinc finger domain protein 1A isoform X3
bromodomain adjacent to zinc finger domain protein 1A isoform X1
bromodomain adjacent to zinc finger domain protein 1A isoform X6
splicing factor 3B subunit 1, transcript variant X1
splicing factor 3B subunit 1, transcript variant X4
splicing factor 3B subunit 1, transcript variant X5
splicing factor 3B subunit 1, transcript variant X2
splicing factor 3B subunit 1, transcript variant X3
splicing factor 3B subunit 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
paired box protein Pax-3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
paired box protein Pax-3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
paired box protein Pax-3-like isoform X2
paired box protein Pax-3-like isoform X1
protein-associating with the carboxyl-terminal domain of ezrin
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 81 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
transcriptional adapter 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transcriptional adapter 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
sodium/bile acid cotransporter 7-like, transcript variant X4
sodium/bile acid cotransporter 7-like, transcript variant X2
sodium/bile acid cotransporter 7-like, transcript variant X3
sodium/bile acid cotransporter 7-like, transcript variant X1
sodium/bile acid cotransporter 7-like isoform X4
sodium/bile acid cotransporter 7-like isoform X2
sodium/bile acid cotransporter 7-like isoform X3
sodium/bile acid cotransporter 7-like isoform X1
cytosolic carboxypeptidase-like protein 5, transcript variant X3
cytosolic carboxypeptidase-like protein 5 isoform X2
cytosolic carboxypeptidase-like protein 5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cytosolic carboxypeptidase-like protein 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
cytosolic carboxypeptidase-like protein 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
cytosolic carboxypeptidase-like protein 5, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
cytosolic carboxypeptidase-like protein 5, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
cytosolic carboxypeptidase-like protein 5 isoform X3
cytosolic carboxypeptidase-like protein 5 isoform X1
cytosolic carboxypeptidase-like protein 5 isoform X4
ARF GTPase-activating protein GIT1, transcript variant X3
ARF GTPase-activating protein GIT1, transcript variant X8
ARF GTPase-activating protein GIT1, transcript variant X5
ARF GTPase-activating protein GIT1, transcript variant X6
ARF GTPase-activating protein GIT1, transcript variant X2
ARF GTPase-activating protein GIT1, transcript variant X4
ARF GTPase-activating protein GIT1, transcript variant X1
ARF GTPase-activating protein GIT1, transcript variant X7
ARF GTPase-activating protein GIT1 isoform X5
ARF GTPase-activating protein GIT1 isoform X3
ARF GTPase-activating protein GIT1 isoform X2
ARF GTPase-activating protein GIT1 isoform X4
ARF GTPase-activating protein GIT1 isoform X1
ARF GTPase-activating protein GIT1 isoform X6
ARF GTPase-activating protein GIT1 isoform X7
uncharacterized protein MAL13P1.304-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein MAL13P1.304-like, transcript variant X4
uncharacterized protein MAL13P1.304-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized protein MAL13P1.304-like, transcript variant X1
uncharacterized protein MAL13P1.304-like, transcript variant X2
uncharacterized protein MAL13P1.304-like isoform X1
uncharacterized protein MAL13P1.304-like isoform X2
ester hydrolase C11orf54 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ester hydrolase C11orf54 homolog, transcript variant X1
uncharacterized LOC124427687, transcript variant X2
uncharacterized LOC124427687, transcript variant X1
uncharacterized protein LOC124427687 isoform X1
uncharacterized protein LOC124427687 isoform X2
endothelin-converting enzyme homolog, transcript variant X1
endothelin-converting enzyme homolog isoform X1
endothelin-converting enzyme homolog, transcript variant X3
endothelin-converting enzyme homolog, transcript variant X2
endothelin-converting enzyme homolog, transcript variant X4
endothelin-converting enzyme homolog, transcript variant X5
endothelin-converting enzyme homolog, transcript variant X6
endothelin-converting enzyme homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cyclin-dependent kinase-like 4, transcript variant X1
cyclin-dependent kinase-like 4, transcript variant X2
cyclin-dependent kinase-like 4 isoform X1
cyclin-dependent kinase-like 2 isoform X2
zinc finger CCHC domain-containing protein 24-like
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
glutaredoxin-C4-like, transcript variant X1
glutaredoxin-C4-like, transcript variant X2
histone acetyltransferase KAT6B, transcript variant X2
histone acetyltransferase KAT6B, transcript variant X3
histone acetyltransferase KAT6B, transcript variant X1
histone acetyltransferase KAT6B isoform X2
histone acetyltransferase KAT6B isoform X1
adenosine kinase 2, transcript variant X2
adenosine kinase 2, transcript variant X1
RNA-binding protein lark, transcript variant X20
RNA-binding protein lark, transcript variant X19
RNA-binding protein lark, transcript variant X15
RNA-binding protein lark, transcript variant X8
RNA-binding protein lark, transcript variant X10
RNA-binding protein lark, transcript variant X16
RNA-binding protein lark, transcript variant X14
RNA-binding protein lark, transcript variant X6
RNA-binding protein lark, transcript variant X1
RNA-binding protein lark, transcript variant X13
RNA-binding protein lark, transcript variant X4
RNA-binding protein lark, transcript variant X2
RNA-binding protein lark, transcript variant X3
RNA-binding protein lark, transcript variant X18
RNA-binding protein lark, transcript variant X9
RNA-binding protein lark, transcript variant X5
RNA-binding protein lark, transcript variant X11
RNA-binding protein lark, transcript variant X17
RNA-binding protein lark, transcript variant X7
RNA-binding protein lark, transcript variant X12
bone morphogenetic protein receptor type-1B, transcript variant X1
bone morphogenetic protein receptor type-1B, transcript variant X3
bone morphogenetic protein receptor type-1B, transcript variant X2
bone morphogenetic protein receptor type-1B isoform X1
bone morphogenetic protein receptor type-1B isoform X3
bone morphogenetic protein receptor type-1B isoform X2
60S ribosomal protein L34-like, transcript variant X2
60S ribosomal protein L34-like, transcript variant X1
ephrin type-B receptor 1-B, transcript variant X24
ephrin type-B receptor 1-B, transcript variant X26
ephrin type-B receptor 1-B, transcript variant X20
ephrin type-B receptor 1-B, transcript variant X14
ephrin type-B receptor 1-B, transcript variant X22
ephrin type-B receptor 1-B, transcript variant X18
ephrin type-B receptor 1-B, transcript variant X9
ephrin type-B receptor 1-B, transcript variant X23
ephrin type-B receptor 1-B, transcript variant X25
ephrin type-B receptor 1-B, transcript variant X19
ephrin type-B receptor 1-B, transcript variant X12
ephrin type-B receptor 1-B, transcript variant X21
ephrin type-B receptor 1-B, transcript variant X17
ephrin type-B receptor 1-B, transcript variant X7
ephrin type-B receptor 1-B, transcript variant X16
ephrin type-B receptor 1-B, transcript variant X13
ephrin type-B receptor 1-B, transcript variant X5
ephrin type-B receptor 1-B, transcript variant X3
ephrin type-B receptor 1-B, transcript variant X15
ephrin type-B receptor 1-B, transcript variant X8
ephrin type-B receptor 1-B, transcript variant X4
ephrin type-B receptor 1-B, transcript variant X11
ephrin type-B receptor 1-B, transcript variant X6
ephrin type-B receptor 1-B, transcript variant X1
ephrin type-B receptor 1-B, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ephrin type-B receptor 1-B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger protein 346-like, transcript variant X1
zinc finger protein 346-like, transcript variant X2
tetratricopeptide repeat protein 12-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
tetratricopeptide repeat protein 12-like isoform X2
tetratricopeptide repeat protein 12-like, transcript variant X1
tetratricopeptide repeat protein 12-like isoform X1
uncharacterized LOC124427651, transcript variant X1
uncharacterized LOC124427651, transcript variant X2
uncharacterized protein LOC124427651 isoform X1
uncharacterized protein LOC124427651 isoform X2
zinc finger CCCH domain-containing protein 13, transcript variant X3
zinc finger CCCH domain-containing protein 13, transcript variant X4
zinc finger CCCH domain-containing protein 13, transcript variant X2
zinc finger CCCH domain-containing protein 13, transcript variant X1
zinc finger CCCH domain-containing protein 13 isoform X2
uncharacterized protein LOC124427645 isoform X1
zinc finger CCCH domain-containing protein 13 isoform X3
U-scoloptoxin(01)-Cw1a-like, transcript variant X2
U-scoloptoxin(01)-Cw1a-like, transcript variant X1
U-scoloptoxin(01)-Cw1a-like, transcript variant X3
U-scoloptoxin(01)-Cw1a-like, transcript variant X4
uncharacterized protein LOC124427444 isoform X1
uncharacterized LOC124427443, transcript variant X1
uncharacterized LOC124427443, transcript variant X6
uncharacterized LOC124427443, transcript variant X2
uncharacterized LOC124427443, transcript variant X4
uncharacterized LOC124427443, transcript variant X5
uncharacterized LOC124427443, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 55% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein lethal(3)malignant blood neoplasm 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC124427545, transcript variant X1
uncharacterized LOC124427545, transcript variant X2
uncharacterized protein LOC124427545 isoform X2
uncharacterized protein LOC124427545 isoform X1
uncharacterized LOC124427464, transcript variant X1
uncharacterized protein LOC124427464 isoform X1
uncharacterized LOC124427464, transcript variant X2
uncharacterized protein LOC124427464 isoform X2
methylcrotonoyl-CoA carboxylase beta chain, mitochondrial, transcript variant X1
methylcrotonoyl-CoA carboxylase beta chain, mitochondrial, transcript variant X3
methylcrotonoyl-CoA carboxylase beta chain, mitochondrial, transcript variant X2
methylcrotonoyl-CoA carboxylase beta chain, mitochondrial isoform X1
methylcrotonoyl-CoA carboxylase beta chain, mitochondrial isoform X2
type-1 angiotensin II receptor-associated protein, transcript variant X2
type-1 angiotensin II receptor-associated protein, transcript variant X1
type-1 angiotensin II receptor-associated protein
transcription factor 12, transcript variant X1
transcription factor 12, transcript variant X8
transcription factor 12, transcript variant X2
transcription factor 12, transcript variant X11
transcription factor 12, transcript variant X9
transcription factor 12, transcript variant X10
transcription factor 12, transcript variant X4
transcription factor 12, transcript variant X12
transcription factor 12, transcript variant X3
transcription factor 12, transcript variant X5
transcription factor 12, transcript variant X6
transcription factor 12, transcript variant X7
transcription factor 12, transcript variant X15
transcription factor 12, transcript variant X13
transcription factor 12, transcript variant X16
transcription factor 12, transcript variant X14
ATP-binding cassette sub-family G member 1-like
uncharacterized LOC124427499, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC124427499, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC124427499, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC124427550, transcript variant X2
uncharacterized LOC124427550, transcript variant X1
zinc finger protein rotund-like, transcript variant X2
zinc finger protein rotund-like, transcript variant X1
zinc finger protein rotund-like, transcript variant X6
zinc finger protein rotund-like, transcript variant X7
zinc finger protein rotund-like, transcript variant X8
zinc finger protein rotund-like, transcript variant X9
zinc finger protein rotund-like, transcript variant X4
zinc finger protein rotund-like, transcript variant X5
zinc finger protein rotund-like, transcript variant X10
zinc finger protein rotund-like, transcript variant X3
zinc finger protein rotund-like, transcript variant X11
uncharacterized protein LOC124427549 isoform X10
uncharacterized protein LOC124427549 isoform X2
uncharacterized protein LOC124427549 isoform X8
uncharacterized protein LOC124427549 isoform X9
uncharacterized protein LOC124427549 isoform X6
zinc finger protein rotund-like isoform X7
uncharacterized protein LOC124427549 isoform X4
uncharacterized protein LOC124427549 isoform X1
uncharacterized protein LOC124427549 isoform X5
uncharacterized protein LOC124427549 isoform X3
uncharacterized protein LOC124427549 isoform X11
histone-lysine N-methyltransferase SETMAR-like
probable ATP-dependent RNA helicase DDX46
reversion-inducing cysteine-rich protein with Kazal motifs
zinc finger-containing ubiquitin peptidase 1-like, transcript variant X10
zinc finger-containing ubiquitin peptidase 1-like, transcript variant X2
zinc finger-containing ubiquitin peptidase 1-like, transcript variant X8
zinc finger-containing ubiquitin peptidase 1-like, transcript variant X9
zinc finger-containing ubiquitin peptidase 1-like, transcript variant X5
zinc finger-containing ubiquitin peptidase 1-like, transcript variant X4
zinc finger-containing ubiquitin peptidase 1-like, transcript variant X6
zinc finger-containing ubiquitin peptidase 1-like, transcript variant X7
zinc finger-containing ubiquitin peptidase 1-like, transcript variant X1
zinc finger-containing ubiquitin peptidase 1-like, transcript variant X3
zinc finger-containing ubiquitin peptidase 1-like isoform X2
zinc finger-containing ubiquitin peptidase 1-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
centrosomal protein of 162 kDa-like, transcript variant X1
centrosomal protein of 162 kDa-like isoform X1
centrosomal protein of 162 kDa-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
centrosomal protein of 162 kDa-like isoform X2
MATH and LRR domain-containing protein PFE0570w-like, transcript variant X2
MATH and LRR domain-containing protein PFE0570w-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
MATH and LRR domain-containing protein PFE0570w-like isoform X1
MATH and LRR domain-containing protein PFE0570w-like isoform X2
TGF-beta-activated kinase 1 and MAP3K7-binding protein 3-like, transcript variant X2
TGF-beta-activated kinase 1 and MAP3K7-binding protein 3-like, transcript variant X3
TGF-beta-activated kinase 1 and MAP3K7-binding protein 3-like, transcript variant X4
TGF-beta-activated kinase 1 and MAP3K7-binding protein 3-like, transcript variant X1
TGF-beta-activated kinase 1 and MAP3K7-binding protein 3-like, transcript variant X5
TGF-beta-activated kinase 1 and MAP3K7-binding protein 3-like, transcript variant X7
TGF-beta-activated kinase 1 and MAP3K7-binding protein 3-like, transcript variant X6
TGF-beta-activated kinase 1 and MAP3K7-binding protein 3-like isoform X1
TGF-beta-activated kinase 1 and MAP3K7-binding protein 3-like isoform X2
chloride intracellular channel exc-4, transcript variant X1
chloride intracellular channel exc-4, transcript variant X2
chloride intracellular channel exc-4 isoform X1
chloride intracellular channel exc-4 isoform X2
PTB domain-containing engulfment adapter protein 1-like, transcript variant X1
PTB domain-containing engulfment adapter protein 1-like, transcript variant X3
PTB domain-containing engulfment adapter protein 1-like, transcript variant X5
PTB domain-containing engulfment adapter protein 1-like, transcript variant X7
PTB domain-containing engulfment adapter protein 1-like, transcript variant X6
PTB domain-containing engulfment adapter protein 1-like, transcript variant X2
PTB domain-containing engulfment adapter protein 1-like, transcript variant X4
PTB domain-containing engulfment adapter protein 1-like
facilitated trehalose transporter Tret1-like, transcript variant X2
facilitated trehalose transporter Tret1-like, transcript variant X5
facilitated trehalose transporter Tret1-like, transcript variant X1
facilitated trehalose transporter Tret1-like, transcript variant X4
facilitated trehalose transporter Tret1-like, transcript variant X3
facilitated trehalose transporter Tret1-like isoform X2
facilitated trehalose transporter Tret1-like isoform X1
facilitated trehalose transporter Tret1-like isoform X3
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial, transcript variant X2
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial isoform X2
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial, transcript variant X1
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial isoform X1
facilitated trehalose transporter Tret1-like
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A-like
cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B, transcript variant X1
cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B, transcript variant X5
cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B, transcript variant X3
cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B, transcript variant X4
cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B, transcript variant X2
cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B isoform X4
cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B isoform X1
cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B isoform X3
cGMP-dependent protein kinase, isozyme 2 forms cD5/T2 isoform X2
cone-rod homeobox protein-like, transcript variant X5
cone-rod homeobox protein-like, transcript variant X4
cone-rod homeobox protein-like, transcript variant X1
cone-rod homeobox protein-like, transcript variant X2
cone-rod homeobox protein-like, transcript variant X6
cone-rod homeobox protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 21% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
BTB/POZ domain-containing protein 6-A, transcript variant X6
BTB/POZ domain-containing protein 6-A, transcript variant X2
BTB/POZ domain-containing protein 6-A, transcript variant X3
BTB/POZ domain-containing protein 6-A, transcript variant X4
BTB/POZ domain-containing protein 6-A, transcript variant X7
BTB/POZ domain-containing protein 6-A, transcript variant X5
BTB/POZ domain-containing protein 6-A, transcript variant X1
BTB/POZ domain-containing protein 6-A isoform X1
BTB/POZ domain-containing protein 6-A isoform X2
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
myb-like protein X, transcript variant X1
myb-like protein X, transcript variant X2
putative uncharacterized protein DDB_G0282133 isoform X2
kinesin-like protein KIF20A, transcript variant X2
kinesin-like protein KIF20A, transcript variant X1
kinesin-like protein KIF20A, transcript variant X3
kinesin-like protein KIF20A, transcript variant X4
similar to RNA sequence (same species):INSD:GBQS01015792.1
annotated by transcript or proteomic data
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 293 bases not found in genome assembly
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 293 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
mitochondrial pyruvate carrier 2-like, transcript variant X1
mitochondrial pyruvate carrier 2-like, transcript variant X2
mitochondrial pyruvate carrier 2-like isoform X1
mitochondrial pyruvate carrier 2-like isoform X2
apoptotic protease-activating factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
apoptotic protease-activating factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
apoptotic protease-activating factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
apoptotic protease-activating factor 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
apoptotic protease-activating factor 1 isoform X2
apoptotic protease-activating factor 1 isoform X1
apoptotic protease-activating factor 1 isoform X3
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA alanine (anticodon UGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon UAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamine (anticodon CUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon UAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC124427214, transcript variant X1
uncharacterized LOC124427214, transcript variant X2
uncharacterized LOC124427216, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124427216, transcript variant X2
uncharacterized LOC124427394, transcript variant X2
uncharacterized LOC124427394, transcript variant X1
uncharacterized protein LOC124427394 isoform X1
uncharacterized protein LOC124427394 isoform X2
uncharacterized LOC124427393, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC124427393, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC124427393 isoform X1
uncharacterized protein LOC124427393 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC124427347, transcript variant X2
uncharacterized LOC124427347, transcript variant X1
uncharacterized protein LOC124427347 isoform X2
uncharacterized protein LOC124427347 isoform X1
transfer RNA glutamine (anticodon UUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA tyrosine (anticodon GUA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC124427347, transcript variant X3
uncharacterized LOC124427347, transcript variant X4
SUMO-activating enzyme subunit 1, transcript variant X2
SUMO-activating enzyme subunit 1, transcript variant X1
leucine-rich repeat neuronal protein 1-like, transcript variant X2
leucine-rich repeat neuronal protein 1-like, transcript variant X1
leucine-rich repeat neuronal protein 1-like isoform X1
leucine-rich repeat neuronal protein 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
transfer RNA leucine (anticodon AAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
epoxide hydrolase 4-like, transcript variant X1
epoxide hydrolase 4-like, transcript variant X3
epoxide hydrolase 4-like, transcript variant X2
WD repeat and HMG-box DNA-binding protein 1
mitochondrial import receptor subunit TOM20 homolog
porphobilinogen deaminase, transcript variant X2
porphobilinogen deaminase, transcript variant X1
BRO1 domain-containing protein BROX-like
lactoylglutathione lyase, transcript variant X1
lactoylglutathione lyase, transcript variant X2
uncharacterized LOC124427433, transcript variant X1
uncharacterized LOC124427433, transcript variant X2
uncharacterized protein LOC124427433 isoform X1
uncharacterized protein LOC124427433 isoform X2
transmembrane protein 41 homolog, transcript variant X1
transmembrane protein 41 homolog, transcript variant X2
transmembrane protein 41 homolog isoform X2
transmembrane protein 41 homolog isoform X1
tumor necrosis factor receptor superfamily member wengen, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member wengen, transcript variant X1
tumor necrosis factor receptor superfamily member wengen isoform X2
tumor necrosis factor receptor superfamily member wengen isoform X1
zinc finger protein ztf-16-like, transcript variant X2
zinc finger protein ztf-16-like, transcript variant X1
zinc finger protein ztf-16-like, transcript variant X3
zinc finger protein ztf-16-like, transcript variant X4
zinc finger protein ztf-16-like isoform X1
zinc finger protein ztf-16-like isoform X2
testis-specific serine/threonine-protein kinase 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
RWD domain-containing protein 2A, transcript variant X1
RWD domain-containing protein 2A, transcript variant X2
F-BAR domain only protein 2, transcript variant X2
F-BAR domain only protein 2, transcript variant X1
F-BAR domain only protein 2, transcript variant X3
F-BAR domain only protein 2, transcript variant X4
microtubule-associated serine/threonine-protein kinase 3, transcript variant X3
microtubule-associated serine/threonine-protein kinase 3, transcript variant X1
microtubule-associated serine/threonine-protein kinase 3, transcript variant X2
microtubule-associated serine/threonine-protein kinase 3 isoform X2
microtubule-associated serine/threonine-protein kinase 3 isoform X3
microtubule-associated serine/threonine-protein kinase 3 isoform X1
metalloendopeptidase OMA1, mitochondrial-like
protein MON2 homolog, transcript variant X1
protein MON2 homolog, transcript variant X2
protein MON2 homolog, transcript variant X3
OTU domain-containing protein 5-A, transcript variant X2
OTU domain-containing protein 5-A, transcript variant X1
OTU domain-containing protein 5-B isoform X1
OTU domain-containing protein 5-B isoform X2
OTU domain-containing protein 5-A, transcript variant X3
OTU domain-containing protein 5-A isoform X3
serine/threonine-protein kinase Nek8-like
uncharacterized LOC124427707, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC124427707, transcript variant X1
MAM and LDL-receptor class A domain-containing protein 1-like
rab11 family-interacting protein 4A, transcript variant X2
rab11 family-interacting protein 4A, transcript variant X3
rab11 family-interacting protein 4A, transcript variant X1
rab11 family-interacting protein 4A, transcript variant X4
EKC/KEOPS complex subunit TP53RK, transcript variant X4
EKC/KEOPS complex subunit TP53RK, transcript variant X1
EKC/KEOPS complex subunit TP53RK, transcript variant X3
EKC/KEOPS complex subunit TP53RK, transcript variant X2
EKC/KEOPS complex subunit TP53RK, transcript variant X5
F-actin-uncapping protein LRRC16A, transcript variant X3
F-actin-uncapping protein LRRC16A, transcript variant X2
F-actin-uncapping protein LRRC16A, transcript variant X4
F-actin-uncapping protein LRRC16A, transcript variant X1
F-actin-uncapping protein LRRC16A isoform X3
F-actin-uncapping protein LRRC16A isoform X2
F-actin-uncapping protein LRRC16A isoform X1
F-actin-uncapping protein LRRC16A isoform X4
F-actin-uncapping protein LRRC16A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
F-actin-uncapping protein LRRC16A isoform X5
glucose-6-phosphate 1-epimerase, transcript variant X2
glucose-6-phosphate 1-epimerase isoform X2
glucose-6-phosphate 1-epimerase, transcript variant X1
glucose-6-phosphate 1-epimerase isoform X1
band 4.1-like protein 3, transcript variant X1
band 4.1-like protein 3, transcript variant X2
band 4.1-like protein 3, transcript variant X3
uncharacterized protein LOC124427357 isoform X1
uncharacterized protein LOC124427357 isoform X3
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
unconventional myosin-Ie-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
unconventional myosin-Ie-like, transcript variant X3
unconventional myosin-Ie-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
unconventional myosin-Ie-like, transcript variant X1
unconventional myosin-Ie-like, transcript variant X4
unconventional myosin-Ie-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
unconventional myosin-Ie-like isoform X3
unconventional myosin-Ie-like isoform X2
unconventional myosin-Ie-like isoform X1
EH domain-binding protein 1, transcript variant X2
EH domain-binding protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 459 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
late embryogenesis abundant protein, group 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
general transcriptional corepressor CYC8-like
uncharacterized LOC124427342, transcript variant X1
uncharacterized LOC124427342, transcript variant X2
uncharacterized LOC124427383, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC124427383, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124427383, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
putative leucine-rich repeat-containing protein DDB_G0290503, transcript variant X3
putative leucine-rich repeat-containing protein DDB_G0290503, transcript variant X1
putative leucine-rich repeat-containing protein DDB_G0290503, transcript variant X5
putative leucine-rich repeat-containing protein DDB_G0290503, transcript variant X2
putative leucine-rich repeat-containing protein DDB_G0290503, transcript variant X4
putative leucine-rich repeat-containing protein DDB_G0290503
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transcription factor 25, transcript variant X1
transcription factor 25, transcript variant X2
leucine-rich repeat-containing protein 59, transcript variant X1
leucine-rich repeat-containing protein 59, transcript variant X2
leucine-rich repeat-containing protein 59
pyruvate dehydrogenase E1 component subunit alpha, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 22% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
uncharacterized LOC124427425, transcript variant X2
uncharacterized LOC124427425, transcript variant X3
uncharacterized LOC124427425, transcript variant X1
uncharacterized protein LOC124427425 isoform X2
uncharacterized protein LOC124427425 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
28S ribosomal protein S35, mitochondrial
uncharacterized LOC124427524, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC124427524, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized protein LOC124427524 isoform X1
uncharacterized protein LOC124427524 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
CAP-Gly domain-containing linker protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CAP-Gly domain-containing linker protein 1-like, transcript variant X2
CAP-Gly domain-containing linker protein 1-like isoform X1
CAP-Gly domain-containing linker protein 1-like isoform X2
cohesin subunit SA-2, transcript variant X2
cohesin subunit SA-2, transcript variant X1
cohesin subunit SA-2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
receptor expression-enhancing protein 5-like
coatomer subunit beta, transcript variant X1
coatomer subunit beta, transcript variant X2
uncharacterized LOC124427387, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
probable cytochrome P450 12b2, mitochondrial, transcript variant X1
probable cytochrome P450 12b2, mitochondrial, transcript variant X2
probable cytochrome P450 12b2, mitochondrial isoform X1
probable cytochrome P450 12b2, mitochondrial isoform X2
uncharacterized LOC124427387, transcript variant X3
uncharacterized LOC124427387, transcript variant X1
protein fem-1 homolog B, transcript variant X3
protein fem-1 homolog B, transcript variant X2
protein fem-1 homolog B, transcript variant X4
protein fem-1 homolog B, transcript variant X1
GTP-binding protein Rheb homolog, transcript variant X3
GTP-binding protein Rheb homolog, transcript variant X1
GTP-binding protein Rheb homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
RNA exonuclease 1, transcript variant X3
RNA exonuclease 1, transcript variant X2
RNA exonuclease 1, transcript variant X1
uncharacterized exonuclease C637.09 isoform X2
putative uncharacterized protein DDB_G0271606, transcript variant X2
putative uncharacterized protein DDB_G0271606, transcript variant X1
putative uncharacterized protein DDB_G0271606 isoform X1
transcription factor SPT20 homolog isoform X2
putative uncharacterized protein DDB_G0271606, transcript variant X3
putative uncharacterized protein DDB_G0271606 isoform X3
uncharacterized LOC124427291, transcript variant X4
uncharacterized LOC124427291, transcript variant X7
uncharacterized LOC124427291, transcript variant X3
uncharacterized LOC124427291, transcript variant X6
uncharacterized LOC124427291, transcript variant X8
uncharacterized LOC124427291, transcript variant X1
uncharacterized protein LOC124427291 isoform X1
uncharacterized LOC124427291, transcript variant X5
uncharacterized LOC124427291, transcript variant X2
uncharacterized protein LOC124427291 isoform X2
uncharacterized protein LOC124427291 isoform X3
uncharacterized protein LOC124427291 isoform X4
importin subunit alpha-7-like, transcript variant X2
importin subunit alpha-7-like, transcript variant X1
zinc finger protein 1, transcript variant X2
zinc finger protein 1, transcript variant X1
trafficking protein particle complex subunit 12
UPF0692 protein CG33108, transcript variant X2
UPF0692 protein CG33108, transcript variant X1
integrator complex subunit 3, transcript variant X1
integrator complex subunit 3, transcript variant X3
integrator complex subunit 3, transcript variant X2
integrator complex subunit 3, transcript variant X6
integrator complex subunit 3, transcript variant X4
integrator complex subunit 3, transcript variant X5
protein groucho-like, transcript variant X5
protein groucho-like, transcript variant X3
protein groucho-like, transcript variant X2
protein groucho-like, transcript variant X1
protein groucho-like, transcript variant X7
protein groucho-like, transcript variant X15
protein groucho-like, transcript variant X8
protein groucho-like, transcript variant X14
protein groucho-like, transcript variant X13
protein groucho-like, transcript variant X12
protein groucho-like, transcript variant X11
protein groucho-like, transcript variant X10
protein groucho-like, transcript variant X9
protein groucho-like, transcript variant X16
protein groucho-like, transcript variant X4
protein groucho-like, transcript variant X6
transducin-like enhancer protein 3 isoform X10
transducin-like enhancer protein 3 isoform X9
protein fem-1 homolog CG6966, transcript variant X3
protein fem-1 homolog CG6966, transcript variant X2
protein fem-1 homolog CG6966, transcript variant X1
protein fem-1 homolog CG6966, transcript variant X4
protein fem-1 homolog CG6966, transcript variant X5
probable isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial
transcription factor SPT20 homolog, transcript variant X1
transcription factor SPT20 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
phosphatidylinositol 3-kinase catalytic subunit type 3
disintegrin and metalloproteinase domain-containing protein 11, transcript variant X3
disintegrin and metalloproteinase domain-containing protein 11, transcript variant X8
disintegrin and metalloproteinase domain-containing protein 11, transcript variant X4
disintegrin and metalloproteinase domain-containing protein 11, transcript variant X13
disintegrin and metalloproteinase domain-containing protein 11, transcript variant X10
disintegrin and metalloproteinase domain-containing protein 11, transcript variant X12
disintegrin and metalloproteinase domain-containing protein 11, transcript variant X5
disintegrin and metalloproteinase domain-containing protein 11, transcript variant X11
disintegrin and metalloproteinase domain-containing protein 11, transcript variant X14
disintegrin and metalloproteinase domain-containing protein 11, transcript variant X6
disintegrin and metalloproteinase domain-containing protein 11, transcript variant X1
disintegrin and metalloproteinase domain-containing protein 11, transcript variant X9
disintegrin and metalloproteinase domain-containing protein 11, transcript variant X7
disintegrin and metalloproteinase domain-containing protein 11, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 12 isoform X2
disintegrin and metalloproteinase domain-containing protein unc-71 isoform X7
disintegrin and metalloproteinase domain-containing protein 12 isoform X3
disintegrin and metalloproteinase domain-containing protein unc-71 isoform X12
disintegrin and metalloproteinase domain-containing protein unc-71 isoform X9
disintegrin and metalloproteinase domain-containing protein 12 isoform X11
disintegrin and metalloproteinase domain-containing protein 12 isoform X4
disintegrin and metalloproteinase domain-containing protein 12 isoform X10
disintegrin and metalloproteinase domain-containing protein 12 isoform X13
disintegrin and metalloproteinase domain-containing protein 12 isoform X5
disintegrin and metalloproteinase domain-containing protein 12 isoform X1
disintegrin and metalloproteinase domain-containing protein 22 isoform X8
disintegrin and metalloproteinase domain-containing protein unc-71 isoform X6
disintegrin and metalloproteinase domain-containing protein 11, transcript variant X16
disintegrin and metalloproteinase domain-containing protein 11, transcript variant X15
disintegrin and metalloproteinase domain-containing protein 11 isoform X15
disintegrin and metalloproteinase domain-containing protein 11 isoform X14
basic-leucine zipper transcription factor A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
basic-leucine zipper transcription factor A, transcript variant X2
basic-leucine zipper transcription factor A, transcript variant X1
basic-leucine zipper transcription factor A isoform X1
basic-leucine zipper transcription factor A isoform X2
cytoplasmic phosphatidylinositol transfer protein 1
uncharacterized LOC124427543, transcript variant X4
uncharacterized LOC124427543, transcript variant X2
uncharacterized protein LOC124427543 isoform X2
uncharacterized LOC124427543, transcript variant X5
uncharacterized LOC124427543, transcript variant X1
uncharacterized LOC124427543, transcript variant X3
uncharacterized protein LOC124427543 isoform X1
uncharacterized protein LOC124427543 isoform X3
probable G-protein coupled receptor 158, transcript variant X1
probable G-protein coupled receptor 158 isoform X1
probable G-protein coupled receptor 158, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
probable G-protein coupled receptor 158 isoform X2
unconventional prefoldin RPB5 interactor-like protein, transcript variant X1
unconventional prefoldin RPB5 interactor-like protein, transcript variant X2
unconventional prefoldin RPB5 interactor-like protein isoform X1
pneumococcal serine-rich repeat protein-like
uncharacterized LOC124427750, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC124427750, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized protein LOC124427750 isoform X1
uncharacterized protein LOC124427750 isoform X2
RISC-loading complex subunit TARBP2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
RISC-loading complex subunit TARBP2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
RISC-loading complex subunit TARBP2-like, transcript variant X3
RISC-loading complex subunit TARBP2-like, transcript variant X2
RISC-loading complex subunit TARBP2-like, transcript variant X5
RISC-loading complex subunit TARBP2-like, transcript variant X6
RISC-loading complex subunit TARBP2-like
dynein axonemal heavy chain 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
dynein axonemal heavy chain 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
dynein axonemal heavy chain 5 isoform X2
dynein axonemal heavy chain 5 isoform X1
uncharacterized LOC124427399, transcript variant X1
uncharacterized LOC124427399, transcript variant X2
uncharacterized LOC124427399, transcript variant X5
uncharacterized LOC124427399, transcript variant X4
lysosomal acid phosphatase-like, transcript variant X1
lysosomal acid phosphatase-like, transcript variant X2
prostatic acid phosphatase-like isoform X1
lysosomal acid phosphatase-like isoform X2
uncharacterized LOC124427399, transcript variant X3
uncharacterized protein LOC124427399 isoform X1
uncharacterized protein LOC124427399 isoform X2
G-protein coupled receptor 52, transcript variant X2
G-protein coupled receptor 52, transcript variant X3
G-protein coupled receptor 52, transcript variant X1
uncharacterized LOC124427727, transcript variant X1
uncharacterized LOC124427727, transcript variant X6
uncharacterized LOC124427727, transcript variant X4
uncharacterized LOC124427727, transcript variant X5
uncharacterized LOC124427727, transcript variant X2
uncharacterized LOC124427727, transcript variant X3
uncharacterized protein LOC124427727 isoform X1
uncharacterized protein LOC124427727 isoform X2
uncharacterized protein LOC124427727 isoform X3
protein LLP homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein LLP homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
probable pathogenesis-related protein CaO19.6200, transcript variant X1
probable pathogenesis-related protein CaO19.6200, transcript variant X4
probable pathogenesis-related protein CaO19.6200, transcript variant X2
uncharacterized protein LOC124427567 isoform X1
uncharacterized protein LOC124427567 isoform X3
probable pathogenesis-related protein CaO19.6200, transcript variant X3
probable pathogenesis-related protein CaO19.6200 isoform X2
probable pathogenesis-related protein CaO19.6200, transcript variant X5
probable pathogenesis-related protein CaO19.6200 isoform X4
potassium channel subfamily T member 2, transcript variant X20
potassium channel subfamily T member 2, transcript variant X23
potassium channel subfamily T member 2, transcript variant X11
potassium channel subfamily T member 2, transcript variant X4
potassium channel subfamily T member 2, transcript variant X7
potassium channel subfamily T member 2, transcript variant X6
potassium channel subfamily T member 2, transcript variant X8
potassium channel subfamily T member 2, transcript variant X10
potassium channel subfamily T member 2, transcript variant X2
potassium channel subfamily T member 2, transcript variant X3
potassium channel subfamily T member 2, transcript variant X9
potassium channel subfamily T member 2, transcript variant X17
potassium channel subfamily T member 2, transcript variant X14
potassium channel subfamily T member 2, transcript variant X12
potassium channel subfamily T member 2, transcript variant X16
potassium channel subfamily T member 2, transcript variant X13
potassium channel subfamily T member 2, transcript variant X15
potassium channel subfamily T member 2, transcript variant X1
potassium channel subfamily T member 2, transcript variant X5
potassium channel subfamily T member 2, transcript variant X19
potassium channel subfamily T member 2, transcript variant X18
potassium channel subfamily T member 2, transcript variant X22
potassium channel subfamily T member 2, transcript variant X21
potassium channel subfamily T member 2, transcript variant X24
potassium channel subfamily T member 2 isoform X12
potassium channel subfamily T member 2 isoform X9
potassium channel subfamily T member 2 isoform X7
potassium channel subfamily T member 2 isoform X4
potassium channel subfamily T member 2 isoform X2
potassium channel subfamily T member 2 isoform X6
potassium channel subfamily T member 2 isoform X3
potassium channel subfamily T member 2 isoform X5
potassium channel subfamily T member 2 isoform X1
potassium channel subfamily T member 2 isoform X11
potassium channel subfamily T member 2 isoform X8
potassium channel subfamily T member 2 isoform X13
potassium channel subfamily T member 2 isoform X10
LON peptidase N-terminal domain and RING finger protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
LON peptidase N-terminal domain and RING finger protein 1, transcript variant X1
LON peptidase N-terminal domain and RING finger protein 1 isoform X1
LON peptidase N-terminal domain and RING finger protein 3 isoform X2
LON peptidase N-terminal domain and RING finger protein 1, transcript variant X3
LON peptidase N-terminal domain and RING finger protein 1 isoform X3
uncharacterized protein KIAA0513, transcript variant X2
uncharacterized protein KIAA0513, transcript variant X3
uncharacterized protein KIAA0513, transcript variant X1
uncharacterized protein KIAA0513 isoform X2
uncharacterized protein KIAA0513 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X7
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X9
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X8
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X11
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X14
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X12
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X6
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X10
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X13
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X3
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X2
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X1
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X5
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X15
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X4
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like isoform X6
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like isoform X3
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like isoform X7
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like isoform X5
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like isoform X4
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like isoform X2
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like isoform X1
transfer RNA threonine (anticodon CGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC124427372, transcript variant X2
uncharacterized LOC124427372, transcript variant X1
zinc transporter ZIP3, transcript variant X1
zinc transporter ZIP3, transcript variant X2
zinc transporter ZIP3, transcript variant X3
probable ATP-dependent RNA helicase DHX34, transcript variant X1
probable ATP-dependent RNA helicase DHX34 isoform X1
probable ATP-dependent RNA helicase DHX34, transcript variant X2
probable ATP-dependent RNA helicase DHX34 isoform X2
pyruvate dehydrogenase E1 component subunit beta, mitochondrial-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
pyruvate dehydrogenase E1 component subunit beta, mitochondrial-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
pyruvate dehydrogenase E1 component subunit beta, mitochondrial-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
pyruvate dehydrogenase E1 component subunit beta, mitochondrial-like, transcript variant X4
GPI mannosyltransferase 2-like isoform X1
pyruvate dehydrogenase E1 component subunit beta, mitochondrial-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pyruvate dehydrogenase E1 component subunit beta, mitochondrial-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
pyruvate dehydrogenase E1 component subunit beta, mitochondrial-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pyruvate dehydrogenase E1 component subunit beta, mitochondrial-like, transcript variant X6
pyruvate dehydrogenase E1 component subunit beta, mitochondrial-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
protein O-mannosyl-transferase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
protein O-mannosyl-transferase 2 isoform X1
protein O-mannosyl-transferase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
protein O-mannosyl-transferase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein O-mannosyl-transferase 2 isoform X2
protein O-mannosyl-transferase 2 isoform X3
probable ATP-dependent RNA helicase spindle-E, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
probable ATP-dependent RNA helicase spindle-E, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
probable ATP-dependent RNA helicase spindle-E, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
probable ATP-dependent RNA helicase spindle-E isoform X1
probable ATP-dependent RNA helicase spindle-E, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
probable ATP-dependent RNA helicase spindle-E isoform X2
protein enabled homolog, transcript variant X2
protein enabled homolog, transcript variant X5
protein enabled homolog, transcript variant X6
protein enabled homolog, transcript variant X3
protein enabled homolog, transcript variant X7
protein enabled homolog, transcript variant X4
protein enabled homolog, transcript variant X8
protein enabled homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
dipeptidyl peptidase 3, transcript variant X2
dipeptidyl peptidase 3, transcript variant X1
DNA polymerase alpha subunit B, transcript variant X2
DNA polymerase alpha subunit B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
DNA polymerase alpha subunit B isoform X1
DNA polymerase alpha subunit B isoform X2
DNA polymerase alpha subunit B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DNA polymerase alpha subunit B isoform X3
steroid hormone receptor ERR2, transcript variant X1
steroid hormone receptor ERR2, transcript variant X3
steroid hormone receptor ERR2, transcript variant X2
steroid hormone receptor ERR2, transcript variant X4
steroid hormone receptor ERR1 isoform X1
steroid hormone receptor ERR2 isoform X3
steroid hormone receptor ERR1 isoform X2
steroid hormone receptor ERR2 isoform X4
steroid hormone receptor ERR2, transcript variant X8
steroid hormone receptor ERR2, transcript variant X5
steroid hormone receptor ERR2, transcript variant X6
steroid hormone receptor ERR2, transcript variant X9
steroid hormone receptor ERR1 isoform X5
steroid hormone receptor ERR2, transcript variant X7
steroid hormone receptor ERR2, transcript variant X11
steroid hormone receptor ERR1 isoform X6
steroid hormone receptor ERR2, transcript variant X10
steroid hormone receptor ERR1 isoform X7
glucose dehydrogenase [FAD, quinone]-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
NPC intracellular cholesterol transporter 2 homolog a-like
neural cell adhesion molecule 1, transcript variant X1
neural cell adhesion molecule 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC124427696, transcript variant X2
uncharacterized LOC124427696, transcript variant X1
uncharacterized LOC124427377, transcript variant X4
uncharacterized LOC124427377, transcript variant X2
uncharacterized LOC124427377, transcript variant X1
uncharacterized LOC124427377, transcript variant X5
uncharacterized LOC124427377, transcript variant X3
DNA fragmentation factor subunit alpha-like, transcript variant X1
DNA fragmentation factor subunit alpha-like, transcript variant X2
DNA fragmentation factor subunit alpha-like, transcript variant X3
DNA fragmentation factor subunit alpha-like
D-beta-hydroxybutyrate dehydrogenase, mitochondrial
vang-like protein 2, transcript variant X1
vang-like protein 2, transcript variant X2
protein dispatched, transcript variant X1
protein dispatched, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
post-GPI attachment to proteins factor 6-like
dynein-1-beta heavy chain, flagellar inner arm I1 complex-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
dynein-1-beta heavy chain, flagellar inner arm I1 complex-like, transcript variant X2
dynein-1-beta heavy chain, flagellar inner arm I1 complex-like isoform X1
dynein-1-beta heavy chain, flagellar inner arm I1 complex-like isoform X2
guanine deaminase, transcript variant X1
guanine deaminase, transcript variant X3
guanine deaminase, transcript variant X2
uncharacterized LOC124427308, transcript variant X1
uncharacterized LOC124427308, transcript variant X2
uncharacterized protein LOC124427308 isoform X2
uncharacterized protein LOC124427308 isoform X1
U3 small nucleolar RNA-interacting protein 2
putative uncharacterized protein DDB_G0289963, transcript variant X1
putative uncharacterized protein DDB_G0289963 isoform X1
putative uncharacterized protein DDB_G0289963, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
putative uncharacterized protein DDB_G0289963 isoform X2
uncharacterized LOC124427542, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124427542, transcript variant X1
WAS/WASL-interacting protein family member 1-like, transcript variant X1
WAS/WASL-interacting protein family member 1-like, transcript variant X2
WAS/WASL-interacting protein family member 1-like isoform X1
WAS/WASL-interacting protein family member 1-like isoform X2
probable H/ACA ribonucleoprotein complex subunit 1
uncharacterized LOC124427258, transcript variant X1
uncharacterized LOC124427258, transcript variant X2
uncharacterized LOC124427258, transcript variant X4
uncharacterized LOC124427258, transcript variant X5
uncharacterized LOC124427258, transcript variant X7
uncharacterized LOC124427258, transcript variant X10
uncharacterized LOC124427258, transcript variant X3
uncharacterized LOC124427258, transcript variant X6
uncharacterized LOC124427258, transcript variant X8
uncharacterized LOC124427258, transcript variant X11
uncharacterized LOC124427258, transcript variant X12
uncharacterized LOC124427258, transcript variant X19
uncharacterized LOC124427258, transcript variant X9
uncharacterized LOC124427258, transcript variant X13
uncharacterized LOC124427258, transcript variant X14
uncharacterized LOC124427258, transcript variant X17
uncharacterized LOC124427258, transcript variant X18
uncharacterized LOC124427258, transcript variant X15
uncharacterized LOC124427258, transcript variant X20
uncharacterized LOC124427258, transcript variant X16
inositol 1,4,5-trisphosphate receptor, transcript variant X4
inositol 1,4,5-trisphosphate receptor, transcript variant X3
inositol 1,4,5-trisphosphate receptor, transcript variant X1
inositol 1,4,5-trisphosphate receptor, transcript variant X2
inositol 1,4,5-trisphosphate receptor isoform X4
inositol 1,4,5-trisphosphate receptor isoform X3
inositol 1,4,5-trisphosphate receptor isoform X2
inositol 1,4,5-trisphosphate receptor isoform X1
striatin-interacting protein 1 homolog, transcript variant X2
striatin-interacting protein 1 homolog, transcript variant X1
striatin-interacting protein 1 homolog isoform X1
striatin-interacting protein 1 homolog isoform X2
glucose-6-phosphate 1-dehydrogenase, transcript variant X1
glucose-6-phosphate 1-dehydrogenase, transcript variant X2
glucose-6-phosphate 1-dehydrogenase isoform X1
glucose-6-phosphate 1-dehydrogenase isoform X2
uncharacterized LOC124427677, transcript variant X1
uncharacterized LOC124427677, transcript variant X2
uncharacterized LOC124427674, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC124427674, transcript variant X1
uncharacterized protein LOC124427674 isoform X2
uncharacterized protein LOC124427674 isoform X1
dual specificity tyrosine-phosphorylation-regulated kinase 2-like
microtubule-associated proteins 1A/1B light chain 3A-like, transcript variant X2
microtubule-associated proteins 1A/1B light chain 3A-like isoform X2
microtubule-associated proteins 1A/1B light chain 3A-like, transcript variant X1
microtubule-associated proteins 1A/1B light chain 3A-like isoform X1
orphan steroid hormone receptor 2, transcript variant X5
orphan steroid hormone receptor 2, transcript variant X1
orphan steroid hormone receptor 2, transcript variant X2
orphan steroid hormone receptor 2 isoform X1
nuclear receptor subfamily 2 group C member 1 isoform X2
orphan steroid hormone receptor 2 isoform X5
orphan steroid hormone receptor 2, transcript variant X6
orphan steroid hormone receptor 2, transcript variant X4
orphan steroid hormone receptor 2, transcript variant X3
orphan steroid hormone receptor 2 isoform X3
orphan steroid hormone receptor 2 isoform X4
orphan steroid hormone receptor 2 isoform X6
MAP kinase-activated protein kinase 2, transcript variant X7
MAP kinase-activated protein kinase 2, transcript variant X6
MAP kinase-activated protein kinase 2, transcript variant X3
MAP kinase-activated protein kinase 2, transcript variant X4
MAP kinase-activated protein kinase 2, transcript variant X5
MAP kinase-activated protein kinase 2, transcript variant X9
MAP kinase-activated protein kinase 2, transcript variant X2
MAP kinase-activated protein kinase 2, transcript variant X8
MAP kinase-activated protein kinase 2, transcript variant X1
MAP kinase-activated protein kinase 2 isoform X1
MAP kinase-activated protein kinase 2 isoform X2
enhancer of mRNA-decapping protein 3, transcript variant X2
enhancer of mRNA-decapping protein 3, transcript variant X3
enhancer of mRNA-decapping protein 3, transcript variant X1
cytochrome c oxidase assembly factor 4 homolog, mitochondrial
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC124427276, transcript variant X2
uncharacterized LOC124427276, transcript variant X1
uncharacterized LOC124427276, transcript variant X15
uncharacterized LOC124427276, transcript variant X16
uncharacterized LOC124427276, transcript variant X14
uncharacterized LOC124427276, transcript variant X6
uncharacterized LOC124427276, transcript variant X13
uncharacterized LOC124427276, transcript variant X12
uncharacterized LOC124427276, transcript variant X11
uncharacterized LOC124427276, transcript variant X8
uncharacterized LOC124427276, transcript variant X9
uncharacterized LOC124427276, transcript variant X4
uncharacterized LOC124427276, transcript variant X3
uncharacterized LOC124427276, transcript variant X10
uncharacterized LOC124427276, transcript variant X7
uncharacterized LOC124427276, transcript variant X5
vesicle transport through interaction with t-SNAREs homolog 1A
long-chain-fatty-acid--CoA ligase 5, transcript variant X1
long-chain-fatty-acid--CoA ligase 5, transcript variant X2
long-chain-fatty-acid--CoA ligase 5 isoform X1
long-chain-fatty-acid--CoA ligase 5 isoform X2
microsomal triacylglycerol transfer protein, transcript variant X3
microsomal triacylglycerol transfer protein, transcript variant X4
microsomal triacylglycerol transfer protein, transcript variant X5
microsomal triacylglycerol transfer protein, transcript variant X2
microsomal triacylglycerol transfer protein, transcript variant X1
microsomal triacylglycerol transfer protein isoform X3
microsomal triacylglycerol transfer protein isoform X2
microsomal triacylglycerol transfer protein isoform X1
microsomal triacylglycerol transfer protein isoform X4
cytochrome P450 4C1-like, transcript variant X2
cytochrome P450 4C1-like, transcript variant X3
cytochrome P450 4C1-like, transcript variant X4
cytochrome P450 4C1-like, transcript variant X6
cytochrome P450 4C1-like, transcript variant X5
cytochrome P450 4C1-like, transcript variant X1
zinc finger protein on ecdysone puffs, transcript variant X1
zinc finger protein on ecdysone puffs, transcript variant X2
GTP-binding protein GEM, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
GTP-binding protein GEM, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
GTP-binding protein GEM, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
GTP-binding protein GEM, transcript variant X2
GTP-binding protein GEM, transcript variant X6
GTP-binding protein GEM, transcript variant X5
GTP-binding protein GEM, transcript variant X7
GTP-binding protein GEM, transcript variant X8
retinoid-inducible serine carboxypeptidase-like, transcript variant X1
retinoid-inducible serine carboxypeptidase-like, transcript variant X2
retinoid-inducible serine carboxypeptidase-like isoform X1
retinoid-inducible serine carboxypeptidase-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
39S ribosomal protein L38, mitochondrial
zinc finger protein 853-like, transcript variant X2
zinc finger protein 853-like, transcript variant X1
chorion transcription factor Cf2-like isoform X2
IQ motif and SEC7 domain-containing protein 1, transcript variant X1
IQ motif and SEC7 domain-containing protein 1 isoform X1
IQ motif and SEC7 domain-containing protein 1, transcript variant X3
IQ motif and SEC7 domain-containing protein 1 isoform X3
IQ motif and SEC7 domain-containing protein 1, transcript variant X2
IQ motif and SEC7 domain-containing protein 1 isoform X2
DNA-binding protein RFXANK-like, transcript variant X1
DNA-binding protein RFXANK-like, transcript variant X2
DNA-binding protein RFXANK-like, transcript variant X3
coatomer subunit delta, transcript variant X2
coatomer subunit delta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
transient receptor potential channel pyrexia, transcript variant X5
transient receptor potential channel pyrexia, transcript variant X3
transient receptor potential channel pyrexia, transcript variant X2
transient receptor potential channel pyrexia, transcript variant X4
transient receptor potential channel pyrexia, transcript variant X1
transient receptor potential channel pyrexia isoform X1
transient receptor potential channel pyrexia isoform X2
transient receptor potential channel pyrexia isoform X3
transient receptor potential channel pyrexia-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
transient receptor potential channel pyrexia-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transient receptor potential channel pyrexia-like
probable arginine--tRNA ligase, mitochondrial, transcript variant X1
probable arginine--tRNA ligase, mitochondrial isoform X1
probable arginine--tRNA ligase, mitochondrial, transcript variant X2
probable arginine--tRNA ligase, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC124427623, transcript variant X3
uncharacterized LOC124427623, transcript variant X2
uncharacterized LOC124427623, transcript variant X1
uncharacterized LOC124427617, transcript variant X1
uncharacterized LOC124427617, transcript variant X3
uncharacterized LOC124427617, transcript variant X6
uncharacterized LOC124427617, transcript variant X2
uncharacterized protein LOC124427617 isoform X1
uncharacterized protein LOC124427617 isoform X2
uncharacterized protein LOC124427617 isoform X5
uncharacterized LOC124427617, transcript variant X5
uncharacterized protein LOC124427617 isoform X4
uncharacterized LOC124427617, transcript variant X4
uncharacterized protein LOC124427617 isoform X3
uncharacterized LOC124427408, transcript variant X2
uncharacterized LOC124427408, transcript variant X1
uncharacterized protein LOC124427408 isoform X2
uncharacterized protein LOC124427408 isoform X1
trafficking protein particle complex subunit 13, transcript variant X1
trafficking protein particle complex subunit 13, transcript variant X2
trafficking protein particle complex subunit 13
PAX3- and PAX7-binding protein 1, transcript variant X3
PAX3- and PAX7-binding protein 1, transcript variant X5
PAX3- and PAX7-binding protein 1, transcript variant X4
PAX3- and PAX7-binding protein 1, transcript variant X1
PAX3- and PAX7-binding protein 1, transcript variant X2
PAX3- and PAX7-binding protein 1 isoform X1
PAX3- and PAX7-binding protein 1 isoform X2
PAX3- and PAX7-binding protein 1, transcript variant X6
PAX3- and PAX7-binding protein 1 isoform X3
vitellogenin-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
vitellogenin-like, transcript variant X2
uncharacterized protein LOC124427445 isoform X1
uncharacterized LOC124427395, transcript variant X1
uncharacterized LOC124427395, transcript variant X3
uncharacterized LOC124427395, transcript variant X2
uncharacterized LOC124427395, transcript variant X5
uncharacterized LOC124427395, transcript variant X4
uncharacterized protein LOC124427395 isoform X1
uncharacterized protein LOC124427395 isoform X2
uncharacterized protein LOC124427395 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase-like
sodium- and chloride-dependent GABA transporter ine, transcript variant X2
sodium- and chloride-dependent GABA transporter ine, transcript variant X1
sodium- and chloride-dependent GABA transporter ine, transcript variant X3
sodium- and chloride-dependent GABA transporter ine isoform X1
sodium- and chloride-dependent GABA transporter ine isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
26S proteasome non-ATPase regulatory subunit 7
protein artichoke, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein artichoke, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
L-threonine 3-dehydrogenase, mitochondrial, transcript variant X2
L-threonine 3-dehydrogenase, mitochondrial, transcript variant X1
L-threonine 3-dehydrogenase, mitochondrial
DNA primase large subunit-like, transcript variant X2
DNA primase large subunit-like, transcript variant X1
acylamino-acid-releasing enzyme-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
acylamino-acid-releasing enzyme-like, transcript variant X2
acylamino-acid-releasing enzyme-like isoform X1
acylamino-acid-releasing enzyme-like isoform X2
uncharacterized LOC124427643, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized protein LOC124427643 isoform X2
uncharacterized LOC124427643, transcript variant X1
uncharacterized LOC124427643, transcript variant X3
uncharacterized protein LOC124427643 isoform X1
UDP-galactose translocator, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
UDP-galactose translocator, transcript variant X2
UDP-galactose translocator, transcript variant X1
RNA polymerase-associated protein CTR9 homolog, transcript variant X2
RNA polymerase-associated protein CTR9 homolog, transcript variant X1
RNA polymerase-associated protein CTR9 homolog, transcript variant X3
RNA polymerase-associated protein CTR9 homolog
dynamin-binding protein-like, transcript variant X1
dynamin-binding protein-like, transcript variant X2
dynamin-binding protein-like, transcript variant X3
quinone oxidoreductase, transcript variant X2
quinone oxidoreductase, transcript variant X1
GATA zinc finger domain-containing protein 15-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
GATA zinc finger domain-containing protein 15-like, transcript variant X1
GATA zinc finger domain-containing protein 15-like, transcript variant X3
GATA zinc finger domain-containing protein 15-like, transcript variant X4
GATA zinc finger domain-containing protein 15-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
GATA zinc finger domain-containing protein 15-like, transcript variant X5
GATA zinc finger domain-containing protein 15-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
IQ and ubiquitin-like domain-containing protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
N-alpha-acetyltransferase 35, NatC auxiliary subunit, transcript variant X2
N-alpha-acetyltransferase 35, NatC auxiliary subunit, transcript variant X1
N-alpha-acetyltransferase 35, NatC auxiliary subunit isoform X2
N-alpha-acetyltransferase 35, NatC auxiliary subunit isoform X1
kinesin-associated protein 3, transcript variant X3
kinesin-associated protein 3, transcript variant X2
kinesin-associated protein 3, transcript variant X1
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cleavage and polyadenylation specificity factor subunit 1, transcript variant X1
cleavage and polyadenylation specificity factor subunit 1 isoform X1
cleavage and polyadenylation specificity factor subunit 1, transcript variant X2
cleavage and polyadenylation specificity factor subunit 1 isoform X2
dynein regulatory complex protein 8-like, transcript variant X2
dynein regulatory complex protein 8-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
dynein regulatory complex protein 8-like isoform X2
dynein regulatory complex protein 8-like isoform X1
dynein regulatory complex protein 8-like, transcript variant X3
dynein regulatory complex protein 8-like, transcript variant X4
dynein regulatory complex protein 8-like isoform X4
dynein regulatory complex protein 8-like isoform X3
delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial, transcript variant X2
delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial, transcript variant X1
delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial isoform X2
delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial isoform X1
retinol dehydrogenase 11-like, transcript variant X2
retinol dehydrogenase 11-like, transcript variant X1
retinol dehydrogenase 11-like, transcript variant X3
UV radiation resistance-associated gene protein, transcript variant X2
UV radiation resistance-associated gene protein, transcript variant X1
UV radiation resistance-associated gene protein isoform X2
UV radiation resistance-associated gene protein isoform X1
rho guanine nucleotide exchange factor 2, transcript variant X5
rho guanine nucleotide exchange factor 2, transcript variant X2
rho guanine nucleotide exchange factor 2, transcript variant X1
rho guanine nucleotide exchange factor 2, transcript variant X3
rho guanine nucleotide exchange factor 2, transcript variant X6
rho guanine nucleotide exchange factor 2, transcript variant X4
rho guanine nucleotide exchange factor 28 isoform X1
rho guanine nucleotide exchange factor 2 isoform X3
rho guanine nucleotide exchange factor 28 isoform X5
rho guanine nucleotide exchange factor 28 isoform X2
rho guanine nucleotide exchange factor 28 isoform X6
rho guanine nucleotide exchange factor 28 isoform X4
rho guanine nucleotide exchange factor 2, transcript variant X9
rho guanine nucleotide exchange factor 2, transcript variant X7
rho guanine nucleotide exchange factor 2, transcript variant X10
rho guanine nucleotide exchange factor 2, transcript variant X8
rho guanine nucleotide exchange factor 28 isoform X7
WD repeat-containing protein 89, transcript variant X2
WD repeat-containing protein 89, transcript variant X1
probable ATP-dependent RNA helicase DHX35
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ceramide phosphoethanolamine synthase
cAMP-dependent protein kinase catalytic subunit 1
uncharacterized LOC124427410, transcript variant X2
uncharacterized LOC124427410, transcript variant X5
uncharacterized LOC124427410, transcript variant X1
uncharacterized LOC124427410, transcript variant X3
uncharacterized LOC124427410, transcript variant X4
neuronal acetylcholine receptor subunit alpha-7-like, transcript variant X8
neuronal acetylcholine receptor subunit alpha-7-like, transcript variant X2
neuronal acetylcholine receptor subunit alpha-7-like, transcript variant X5
neuronal acetylcholine receptor subunit alpha-7-like, transcript variant X6
neuronal acetylcholine receptor subunit alpha-7-like, transcript variant X3
neuronal acetylcholine receptor subunit alpha-7-like, transcript variant X4
neuronal acetylcholine receptor subunit alpha-7-like, transcript variant X1
neuronal acetylcholine receptor subunit alpha-7-like, transcript variant X7
acetylcholine receptor subunit alpha-type acr-16-like isoform X4
neuronal acetylcholine receptor subunit alpha-7-like isoform X1
neuronal acetylcholine receptor subunit alpha-7-like isoform X2
acetylcholine receptor subunit alpha-type acr-16-like isoform X3
uncharacterized LOC124427270, transcript variant X3
uncharacterized LOC124427270, transcript variant X1
uncharacterized LOC124427270, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC124427270 isoform X1
uncharacterized protein LOC124427270 isoform X2
POU domain, class 3, transcription factor 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
endocuticle structural glycoprotein SgAbd-1-like
endocuticle structural glycoprotein SgAbd-8-like
endocuticle structural glycoprotein SgAbd-4-like
endocuticle structural glycoprotein SgAbd-2-like
transmembrane protein 181, transcript variant X2
transmembrane protein 181, transcript variant X1
transmembrane protein 181, transcript variant X3
ras-related protein Rab-8A, transcript variant X1
ras-related protein Rab-8A, transcript variant X2
isopentenyl-diphosphate Delta-isomerase 1
protein Wnt-11b-2-like, transcript variant X1
protein Wnt-11b-2-like, transcript variant X2
EF-hand domain-containing family member C2, transcript variant X1
EF-hand domain-containing family member C2 isoform X1
EF-hand domain-containing family member C2, transcript variant X2
EF-hand domain-containing family member C2 isoform X2
extended synaptotagmin-1, transcript variant X2
extended synaptotagmin-1, transcript variant X4
extended synaptotagmin-1, transcript variant X1
extended synaptotagmin-1, transcript variant X5
extended synaptotagmin-1, transcript variant X3
probable serine incorporator, transcript variant X1
probable serine incorporator, transcript variant X2
probable serine incorporator, transcript variant X3
probable serine incorporator, transcript variant X4
probable serine incorporator, transcript variant X5
probable serine incorporator, transcript variant X6
nose resistant to fluoxetine protein 6-like, transcript variant X3
nose resistant to fluoxetine protein 6-like, transcript variant X4
nose resistant to fluoxetine protein 6-like, transcript variant X2
nose resistant to fluoxetine protein 6-like, transcript variant X1
nose resistant to fluoxetine protein 6-like isoform X3
nose resistant to fluoxetine protein 6-like isoform X4
nose resistant to fluoxetine protein 6-like isoform X2
nose resistant to fluoxetine protein 6-like isoform X1
cAMP-dependent protein kinase inhibitor beta-like, transcript variant X2
uncharacterized protein LOC124427247 isoform X2
cAMP-dependent protein kinase inhibitor beta-like, transcript variant X1
uncharacterized protein LOC124427247 isoform X1
cAMP-dependent protein kinase inhibitor beta-like, transcript variant X3
cAMP-dependent protein kinase inhibitor beta-like isoform X3
gustatory receptor 5a for trehalose-like, transcript variant X1
gustatory receptor 5a for trehalose-like, transcript variant X3
gustatory receptor 5a for trehalose-like, transcript variant X4
gustatory receptor 5a for trehalose-like, transcript variant X2
gustatory receptor 5a for trehalose-like isoform X1
gustatory receptor 5a for trehalose-like isoform X3
gustatory receptor 5a for trehalose-like isoform X4
gustatory receptor 5a for trehalose-like isoform X2
gustatory receptor for sugar taste 64f-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
elongation factor 1-alpha, transcript variant X1
elongation factor 1-alpha, transcript variant X3
elongation factor 1-alpha, transcript variant X2
uncharacterized LOC124427245, transcript variant X2
uncharacterized LOC124427245, transcript variant X1
cGMP-gated cation channel alpha-1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
cGMP-gated cation channel alpha-1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
cGMP-gated cation channel alpha-1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cGMP-gated cation channel alpha-1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cGMP-gated cation channel alpha-1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
cGMP-gated cation channel alpha-1, transcript variant X2
cGMP-gated cation channel alpha-1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
cGMP-gated cation channel alpha-1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
cGMP-gated cation channel alpha-1, transcript variant X9
cGMP-gated cation channel alpha-1, transcript variant X1
cGMP-gated cation channel alpha-1 isoform X4
cGMP-gated cation channel alpha-1 isoform X2
cGMP-gated cation channel alpha-1 isoform X3
cGMP-gated cation channel alpha-1 isoform X1
ATP synthase mitochondrial F1 complex assembly factor 1
molybdenum cofactor biosynthesis protein 1, transcript variant X1
molybdenum cofactor biosynthesis protein 1, transcript variant X2
molybdenum cofactor biosynthesis protein 1 isoform X1
molybdenum cofactor biosynthesis protein 1 isoform X2
zwei Ig domain protein zig-8-like, transcript variant X2
zwei Ig domain protein zig-8-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zwei Ig domain protein zig-8-like, transcript variant X1
zwei Ig domain protein zig-8-like, transcript variant X4
zwei Ig domain protein zig-8-like, transcript variant X5
zwei Ig domain protein zig-8-like isoform X4
zwei Ig domain protein zig-8-like isoform X5
zwei Ig domain protein zig-8-like isoform X2
zwei Ig domain protein zig-8-like isoform X3
zwei Ig domain protein zig-8-like isoform X1
dynein light chain Tctex-type protein 2B-like
muscle calcium channel subunit alpha-1, transcript variant X8
muscle calcium channel subunit alpha-1, transcript variant X9
muscle calcium channel subunit alpha-1, transcript variant X10
muscle calcium channel subunit alpha-1, transcript variant X7
muscle calcium channel subunit alpha-1, transcript variant X1
muscle calcium channel subunit alpha-1, transcript variant X4
muscle calcium channel subunit alpha-1, transcript variant X6
muscle calcium channel subunit alpha-1, transcript variant X3
muscle calcium channel subunit alpha-1, transcript variant X2
muscle calcium channel subunit alpha-1, transcript variant X5
muscle calcium channel subunit alpha-1 isoform X6
muscle calcium channel subunit alpha-1 isoform X8
muscle calcium channel subunit alpha-1 isoform X5
muscle calcium channel subunit alpha-1 isoform X3
muscle calcium channel subunit alpha-1 isoform X1
muscle calcium channel subunit alpha-1 isoform X2
muscle calcium channel subunit alpha-1 isoform X4
muscle calcium channel subunit alpha-1 isoform X7
dnaJ homolog subfamily C member 2, transcript variant X2
dnaJ homolog subfamily C member 2, transcript variant X3
dnaJ homolog subfamily C member 2, transcript variant X1
dnaJ homolog subfamily C member 2 isoform X1
dnaJ homolog subfamily C member 2 isoform X2
Na(+)/H(+) exchange regulatory cofactor NHE-RF1
uncharacterized LOC124427332, transcript variant X2
uncharacterized LOC124427332, transcript variant X1
uncharacterized LOC124427332, transcript variant X3
uncharacterized protein LOC124427332 isoform X1
uncharacterized protein LOC124427332 isoform X2
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X3
aryl hydrocarbon receptor nuclear translocator homolog isoform X3
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X1
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X2
aryl hydrocarbon receptor nuclear translocator homolog isoform X1
aryl hydrocarbon receptor nuclear translocator homolog isoform X2
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X5
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X4
aryl hydrocarbon receptor nuclear translocator homolog isoform X4
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X6
aryl hydrocarbon receptor nuclear translocator homolog isoform X5
aryl hydrocarbon receptor nuclear translocator homolog isoform X6
U3 small nucleolar ribonucleoprotein protein MPP10
spectrin alpha chain, non-erythrocytic 1, transcript variant X5
spectrin alpha chain, non-erythrocytic 1, transcript variant X6
spectrin alpha chain, non-erythrocytic 1, transcript variant X1
spectrin alpha chain, non-erythrocytic 1, transcript variant X3
spectrin alpha chain, non-erythrocytic 1, transcript variant X2
spectrin alpha chain, non-erythrocytic 1, transcript variant X4
spectrin alpha chain, non-erythrocytic 1 isoform X3
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6-like, transcript variant X8
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6-like, transcript variant X7
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6-like, transcript variant X1
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6-like, transcript variant X5
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6-like, transcript variant X2
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6-like, transcript variant X6
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6-like isoform X4
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6-like isoform X1
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6-like isoform X2
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6-like isoform X5
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6-like, transcript variant X9
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6-like, transcript variant X10
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6-like, transcript variant X4
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6-like, transcript variant X3
tRNA pseudouridine synthase Pus10, transcript variant X1
tRNA pseudouridine synthase Pus10, transcript variant X2
tRNA pseudouridine synthase Pus10 isoform X1
tRNA pseudouridine synthase Pus10 isoform X2
facilitated trehalose transporter Tret1-2 homolog
uncharacterized LOC124427333, transcript variant X4
uncharacterized LOC124427333, transcript variant X2
uncharacterized LOC124427333, transcript variant X1
uncharacterized LOC124427333, transcript variant X3
uncharacterized protein LOC124427333 isoform X2
uncharacterized protein LOC124427333 isoform X3
uncharacterized protein LOC124427333 isoform X1
uncharacterized protein LOC124427333 isoform X4
uncharacterized LOC124427469, transcript variant X4
uncharacterized LOC124427469, transcript variant X2
uncharacterized LOC124427469, transcript variant X1
uncharacterized LOC124427469, transcript variant X3
uncharacterized LOC124427469, transcript variant X6
uncharacterized LOC124427469, transcript variant X5
uncharacterized protein LOC124427469 isoform X3
uncharacterized protein LOC124427469 isoform X1
uncharacterized protein LOC124427469 isoform X2
quinone oxidoreductase-like protein 2, transcript variant X1
quinone oxidoreductase-like protein 2, transcript variant X2
quinone oxidoreductase-like protein 2, transcript variant X3
quinone oxidoreductase-like protein 2 isoform X1
quinone oxidoreductase-like protein 2 isoform X2
quinone oxidoreductase-like protein 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
rho GTPase-activating protein 100F, transcript variant X1
rho GTPase-activating protein 100F, transcript variant X4
rho GTPase-activating protein 100F, transcript variant X5
rho GTPase-activating protein 100F, transcript variant X7
rho GTPase-activating protein 100F, transcript variant X3
rho GTPase-activating protein 100F, transcript variant X2
rho GTPase-activating protein 100F isoform X1
rho GTPase-activating protein 100F isoform X2
rho GTPase-activating protein 100F isoform X3
rho GTPase-activating protein 100F isoform X5
rho GTPase-activating protein 100F, transcript variant X6
rho GTPase-activating protein 100F isoform X4
structural maintenance of chromosomes protein 2, transcript variant X1
structural maintenance of chromosomes protein 2 isoform X1
structural maintenance of chromosomes protein 2, transcript variant X2
structural maintenance of chromosomes protein 2 isoform X2
vacuolar protein sorting-associated protein 37B
dnaJ homolog subfamily C member 30, mitochondrial-like
26S proteasome non-ATPase regulatory subunit 6
4-hydroxybenzoate polyprenyltransferase, mitochondrial, transcript variant X1
4-hydroxybenzoate polyprenyltransferase, mitochondrial, transcript variant X3
4-hydroxybenzoate polyprenyltransferase, mitochondrial, transcript variant X2
4-hydroxybenzoate polyprenyltransferase, mitochondrial, transcript variant X6
4-hydroxybenzoate polyprenyltransferase, mitochondrial, transcript variant X5
4-hydroxybenzoate polyprenyltransferase, mitochondrial, transcript variant X4
4-hydroxybenzoate polyprenyltransferase, mitochondrial isoform X2
4-hydroxybenzoate polyprenyltransferase, mitochondrial isoform X1
4-hydroxybenzoate polyprenyltransferase, mitochondrial isoform X3
putative protein FAM10A4, transcript variant X3
putative protein FAM10A4, transcript variant X1
putative protein FAM10A4, transcript variant X2
eukaryotic translation initiation factor 5B
electron transfer flavoprotein subunit alpha, mitochondrial
trifunctional enzyme subunit beta, mitochondrial, transcript variant X1
trifunctional enzyme subunit beta, mitochondrial, transcript variant X2
trifunctional enzyme subunit beta, mitochondrial isoform X1
trifunctional enzyme subunit beta, mitochondrial isoform X2
chromatin assembly factor 1 subunit B, transcript variant X2
chromatin assembly factor 1 subunit B, transcript variant X1
chromatin assembly factor 1 subunit B isoform X1
chromatin assembly factor 1 subunit B isoform X2
tRNA-splicing endonuclease subunit Sen34
uncharacterized LOC124427591, transcript variant X3
uncharacterized LOC124427591, transcript variant X1
uncharacterized LOC124427591, transcript variant X4
uncharacterized LOC124427591, transcript variant X2